$2.755
-0.208 (-7.55%)收盘时
CNSY 盈利能力与利润率
Evaluating the bottom line, Cerenome, Inc maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -2203.65%, while the net margin is -2191.24%. These profitability ratios, combined with a Return on Equity (ROE) of -614.05%, provide a clear picture of how effectively CNSY converts its operational activities into shareholder value.
CNSY 同业对比
In the context of the broader market, CNSY competes directly with industry leaders such as GNTA and BFRI. With a market capitalization of $22.31M, it holds a significant position in the sector. When comparing efficiency, CNSY's gross margin of 100.00% stands against GNTA's N/A and BFRI's 79.92%. Such benchmarking helps identify whether Cerenome, Inc is trading at a premium or discount relative to its financial performance.
CNSY 财务表现
The company has reported significant net losses, with a net income of -9006000 in Q2 2026 and a negative EPS of -1.31. Furthermore, the gross margin remains at 100%, but this does not compensate for the overall negative financial outlook.
Financials
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。